Berberine Inhibits the gene Expression and Production of Proinflammatory Cytokines by Mononuclear cells in Rheumatoid Arthritis and Healthy Individuals
- Objective: Rheumatoid arthritis (RA) is the most prevalent autoimmune arthritis. Berberine is an alkaloid isolated from Berberis vulgaris and its anti-inflammatory effect has been identified.
- Method: Twenty newly diagnosed RA patients and 20 healthy controls participated. Peripheral mononuclear cells were prepared and stimulated with bacterial lipopolysachharide (LPS,1 µg/ml), exposed to different concentrations of berberine (10 and 50µM) and dexamethasone (10-7 M) as a reference. Toxicity of compounds was evaluated by WST-1 assay. Expression of TNF-α and IL-1β were determined by quantitative real-time PCR. Protein level of secreted TNF-α and IL1β were measured by using ELISA.
- Result: Berberine did not have any toxic effect on cells, whereas Lipopolysachharide (LPS) stimulation caused a noticeable rise in TNF-α and IL-1β production. Berberine markedly downregulated the expression of both TNF-α and IL1β and inhibits TNF-α and IL-1β secretion from LPS-stimulated PBMCs.
- Discussion: This study provided molecular basis for anti-inflammatory effect of berberine on human mononuclear cells through the suppression of TNF-a and IL-1secretion. Our findings highlighted the significant inhibitory effect of berberine on proinflammatory responses of mononuclear cells from rheumatoid arthritis individuals, which may be responsible for antiinflammatory property of Barberry. We observed that berberine at high concentration exhibited anti-inflammatory effect in PBMCs of both healthy and patient groups by suppression of TNF-a and IL-1cytokines at both mRNA and protein levels.
- Conclusions: Berberine may inhibit the gene expression and production of pro-inflammatory cytokines by mononuclear cells in rheumatoid arthritis and healthy individuals without affecting cells viability. Future studies with larger sample size is needed to prove the idea.
Parainfluenza Type 3 Antigen |
|||
| MBS318453-5x1mL | MyBiosource | 5x1mL | EUR 2425 |
Canine Parainfluenza Virus Antigen |
|||
| NAT41593-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|||
Parainfluenza Virus Type 2 Antigen |
|||
| BA1262VS | Genovis AB | 1mg | EUR 917 |
Parainfluenza Virus Type 2 Antigen |
|||
| PR-BA1262-L | Jena Bioscience GmbH | 1mg | EUR 831.9 |
|
Description: native, Vero cell culture |
|||
Parainfluenza Virus Type 2 Antigen |
|||
| PR-BA1262-S | Jena Bioscience GmbH | 250µg | EUR 276.92 |
|
Description: native, Vero cell culture |
|||
Parainfluenza Type-1 Virus Antigen |
|||
| VAC-0319 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
Parainfluenza Type-3 Virus Antigen |
|||
| VAC-0320 | Creative BioMart | 0.5ml | EUR 1598.4 |
|
Description: Protein |
|||
Parainfluenza Virus Type 1 Antigen |
|||
| BA1261VS | Genovis AB | 1mg | EUR 917 |
Parainfluenza Virus Type 3 Antigen |
|||
| BA1263VS | Genovis AB | 1mg | EUR 485 |
Parainfluenza Virus Type 1 Antigen |
|||
| PR-BA1261-L | Jena Bioscience GmbH | 1mg | EUR 831.9 |
|
Description: native, MDCK cell culture |
|||
Parainfluenza Virus Type 1 Antigen |
|||
| PR-BA1261-S | Jena Bioscience GmbH | 250µg | EUR 276.92 |
|
Description: native, MDCK cell culture |
|||
Parainfluenza Virus Type 3 Antigen |
|||
| PR-BA1263-L | Jena Bioscience GmbH | 1mg | EUR 831.9 |
|
Description: native, Vero cell culture |
|||
Parainfluenza Virus Type 3 Antigen |
|||
| PR-BA1263-S | Jena Bioscience GmbH | 250µg | EUR 276.92 |
|
Description: native, Vero cell culture |
|||
OPMA04417-1ML - Parainfluenza Type 2 Antigen Protein |
|||
| OPMA04417-1ML | Aviva Systems Biology | 1ml | EUR 559 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (HRP) |
|||
| MBS6262618-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (HRP) |
|||
| MBS6262618-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (PE) |
|||
| MBS6263129-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (PE) |
|||
| MBS6263129-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (AP) |
|||
| MBS6260578-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (AP) |
|||
| MBS6260578-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (APC) |
|||
| MBS6261089-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (APC) |
|||
| MBS6261089-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (FITC) |
|||
| MBS6262108-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (FITC) |
|||
| MBS6262108-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Virus type 2 (PIV-2) Antigen, Grade 2 |
|||
| MBS568584-1mL | MyBiosource | 1mL | EUR 690 |
Parainfluenza Virus type 2 (PIV-2) Antigen, Grade 2 |
|||
| MBS568584-5x1mL | MyBiosource | 5x1mL | EUR 2830 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (Biotin) |
|||
| MBS6261599-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (Biotin) |
|||
| MBS6261599-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
OPMA04406-1ML - Parainfluenza Type 3 Antigen Protein |
|||
| OPMA04406-1ML | Aviva Systems Biology | 1ml | EUR 559 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 550) |
|||
| MBS6264662-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 550) |
|||
| MBS6264662-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 650) |
|||
| MBS6265173-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 650) |
|||
| MBS6265173-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 750) |
|||
| MBS6265684-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 750) |
|||
| MBS6265684-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 490) |
|||
| MBS6264151-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 490) |
|||
| MBS6264151-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 405) |
|||
| MBS6263640-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 2 (Parainfluenza Virus Type 2, Parainfluenza 2) (MaxLight 405) |
|||
| MBS6263640-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Human Parainfluenza Virus Type 1 Lysate |
|||
| NAT41619-100 | The Native Antigen Company | 0.1 | EUR 517.6 |
|
Description: Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
|||
Human Parainfluenza Virus Type 3 Lysate |
|||
| NAT41621-100 | The Native Antigen Company | 0.1 | EUR 517.6 |
|
Description: Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
|||
Human Parainfluenza Virus Type 3 Lysate |
|||
| NAT41621-500 | The Native Antigen Company | 0.5 | EUR 2201.73 |
|
Description: Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
|||
Human Parainfluenza Virus Type 4A Lysate |
|||
| NAT41622-100 | The Native Antigen Company | 0.1 | EUR 517.6 |
|
Description: Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
|||
Human Parainfluenza Virus Type 4A Lysate |
|||
| NAT41622-500 | The Native Antigen Company | 0.5 | EUR 2201.73 |
|
Description: Parainfluenza Virus is an enveloped, negative-sense single-stranded RNA virus with a diameter of approximately 150 to 250 nm. |
|||
Parainfluenza Virus type 3 (PIV-3) Antigen, Grade 2 |
|||
| MBS568731-1mL | MyBiosource | 1mL | EUR 690 |
Parainfluenza Virus type 3 (PIV-3) Antigen, Grade 2 |
|||
| MBS568731-5x1mL | MyBiosource | 5x1mL | EUR 2830 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (AP) |
|||
| MBS6450398-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (AP) |
|||
| MBS6450398-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (APC) |
|||
| MBS6450399-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (APC) |
|||
| MBS6450399-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (HRP) |
|||
| MBS6450402-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (HRP) |
|||
| MBS6450402-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (PE) |
|||
| MBS6450408-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (PE) |
|||
| MBS6450408-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (HRP) |
|||
| MBS6262617-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (HRP) |
|||
| MBS6262617-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (HRP) |
|||
| MBS6262619-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (HRP) |
|||
| MBS6262619-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (PE) |
|||
| MBS6263128-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (PE) |
|||
| MBS6263128-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (PE) |
|||
| MBS6263130-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (PE) |
|||
| MBS6263130-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (AP) |
|||
| MBS6260577-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (AP) |
|||
| MBS6260577-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (AP) |
|||
| MBS6260579-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (AP) |
|||
| MBS6260579-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (APC) |
|||
| MBS6261088-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (APC) |
|||
| MBS6261088-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (APC) |
|||
| MBS6261090-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (APC) |
|||
| MBS6261090-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (FITC) |
|||
| MBS6450401-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (FITC) |
|||
| MBS6450401-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (FITC) |
|||
| MBS6262107-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (FITC) |
|||
| MBS6262107-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (FITC) |
|||
| MBS6262109-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (FITC) |
|||
| MBS6262109-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (Biotin) |
|||
| MBS6450400-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (Biotin) |
|||
| MBS6450400-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (Biotin) |
|||
| MBS6261598-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (Biotin) |
|||
| MBS6261598-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (Biotin) |
|||
| MBS6261600-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (Biotin) |
|||
| MBS6261600-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
OPEF01532-1ML - Parainfluenza Virus type 2 (PIV-2) Grade 2 Antigen |
|||
| OPEF01532-1ML | Aviva Systems Biology | 1ml | EUR 635 |
Parainfluenza Type-2 |
|||
| iha-029 | ProSpec Tany | 10µg | EUR 60 |
|
Description: Parainfluenza Virus Type-2 |
|||
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 405) |
|||
| MBS6450403-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 405) |
|||
| MBS6450403-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 490) |
|||
| MBS6450404-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 490) |
|||
| MBS6450404-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 550) |
|||
| MBS6450405-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 550) |
|||
| MBS6450405-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 650) |
|||
| MBS6450406-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 650) |
|||
| MBS6450406-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 750) |
|||
| MBS6450407-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 750) |
|||
| MBS6450407-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 550) |
|||
| MBS6264661-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 550) |
|||
| MBS6264661-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 550) |
|||
| MBS6264663-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 550) |
|||
| MBS6264663-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 650) |
|||
| MBS6265172-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 650) |
|||
| MBS6265172-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 650) |
|||
| MBS6265174-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 650) |
|||
| MBS6265174-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 750) |
|||
| MBS6265683-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 750) |
|||
| MBS6265683-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 750) |
|||
| MBS6265685-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 750) |
|||
| MBS6265685-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 490) |
|||
| MBS6264150-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 490) |
|||
| MBS6264150-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 490) |
|||
| MBS6264152-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 490) |
|||
| MBS6264152-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 405) |
|||
| MBS6263639-01mL | MyBiosource | 0.1mL | EUR 680 |
Parainfluenza Type 1 (Parainfluenza Virus Type 1, Parainfluenza 1) (MaxLight 405) |
|||
| MBS6263639-5x01mL | MyBiosource | 5x0.1mL | EUR 2920 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 405) |
|||
| MBS6263641-01mL | MyBiosource | 0.1mL | EUR 915 |
Parainfluenza Type 3 (Parainfluenza Virus Type 3, Parainfluenza 3) (MaxLight 405) |
|||
| MBS6263641-5x01mL | MyBiosource | 5x0.1mL | EUR 3955 |
Parainfluenza type 2 antibody |
|||
| 10-P53A | Fitzgerald | 1 mg | EUR 435 |
|
Description: Mouse monoclonal Parainfluenza type 2 antibody |
|||
Parainfluenza type 2 antibody |
|||
| 10-P53B | Fitzgerald | 1 mg | EUR 95 |
|
Description: Mouse monoclonal Parainfluenza type 2 antibody |
|||
Parainfluenza type 2 antibody |
|||
| 10C-CR3015M1 | Fitzgerald | 100 ug | EUR 166 |
|
Description: Mouse monoclonal Parainfluenza type 2 antibody |
|||
Parainfluenza Type 2 Antibody |
|||
| abx022124-1mg | Abbexa | 1 mg | EUR 1387.2 |
Parainfluenza Type 2 Antibody |
|||
| abx022124-400l | Abbexa | 400 µl | Ask for price |
Brain Network Connectivity and Association with Catechol-O-Methyltransferase Gene Polymorphism in Korean Attention-Deficit Hyperactivity Disorder Children
Objective: We sought to determine if the links between and within the default mode network (DMN) and dorsal attention network (DAT) exhibited different conditions according to catechol-O-methyltransferase (COMT) gene polymorphism in relationship to attention-deficit hyperactivity disorder (ADHD) symptoms.
Methods: Fifty-seven children with ADHD and 48 healthy controls (HCs) were administered an intelligence test, the Children’s Depression Inventory, the Korean ADHD rating scale, and continuous performance test. Resting-state brain functional MRI scans were obtained, and COMT genotyping was performed to distinguish valine carriers and methionine homozygotes.
Results: Compared to controls, children with ADHD showed increased ADHD scale scores, increased visual commission errors, and increased functional connectivity (FC) within the DMN and DAT. Compared to all children with ADHD, children with the methionine homozygote and those who were valine carriers showed increased FC within the DMN and DAT and decreased FC between the DMN and DAT. FC within the DMN was also increased in HC valine carriers compared to HC children with the methionine homozygote, and in children with ADHD who were valine carriers compared to HC valine carriers.
Conclusion: We observed increased brain connectivity within the DMN and DAT and altered brain connectivity within and between the DMN and DAT associated with COMT polymorphism in children with ADHD.
Ovarian cancer predisposition beyond BRCA1 and BRCA2 genes
Several genes associated with hereditary ovarian cancer have been discovered as a result of the work done with next generation sequencing. It is estimated that approximately 23% of ovarian carcinomas have a hereditary predisposition. The most common hereditary condition is represented by germline mutations in BRCA1 or BRCA2 genes that account for 20-25% of high grade serous ovarian cancer.
A number of other hereditary ovarian cancers are associated with different genes, with a crucial role in the DNA damage response pathway, such as the mismatch repair genes in Lynch syndrome, TP53 in Li-Fraumeni syndrome, STK11 in Peutz-Jeghers syndrome, CHEK2, RAD51, BRIP1, and PALB2. The goal of this manuscript is to summarize the published data regarding the molecular pathways involved in the pathogenesis of non-BRCA related hereditary ovarian cancer and to provide a tool that might be useful in discussing risk assessment, genetic testing, prevention strategies, as well as clinical and therapeutic implications for patients with ovarian cancer.
Transcriptome analysis of duck embryo fibroblasts for the dynamic response to duck tembusu virus infection and dual regulation of apoptosis genes
Duck Tembusu virus (DTMUV) is an emerging pathogenic flavivirus that has caused enormous economic losses in Southeast Asia. However, the pathogenic mechanism and host’s responses after DTMUV infection remain poorly understood. During this study, total mRNA sequencing (RNA-Seq) analysis was used to detect the global gene expression in DEFs at various time points after DTMUV infection.
We identified 326 genes altered significantly at all time points, and these genes were dynamically enriched in multifarious biological processes, including apoptosis, innate immune response, DNA replication, cell cycle arrest and DNA repair. Next, the results showed that apoptosis was induced and the proportion of apoptosis increased with time, and pro-apoptotic molecules caspases were activated.
The RNA-seq data analysis further revealed that most pro-apoptosis and anti-apoptosis genes were early continually responsive, and the genes involved in both intrinsic and extrinsic apoptotic pathways were initiated. Further, the considerably enriched immune-relevant pathways were involved in apoptosis process, and protein-protein interactions (PPIs) analysis showed that IL6, STAT1, TNFAIP3, CFLAR and PTGS2 may be key regulators of DEFs apoptosis. In conclusion, this study not only contributes to understanding the underlying mechanism of DEFs infection with DTMUV, but also provides new insights into targets screening for antiviral therapy.
Ro/SS-A Antigen (Ro-60/SS-A) |
|||
| MBS651599-5x1000Units | MyBiosource | 5x1000Units | EUR 5710 |
SS-A (Ro) Antigen |
|||
| GWB-977C72 | GenWay Biotech | 1000 TESTS | Ask for price |
SS-A (Ro) Antigen |
|||
| GWB-E89B9A | GenWay Biotech | 0.2 mg | Ask for price |
SS-A (Ro) Antigen |
|||
| MBS318013-1000Units | MyBiosource | 1000Units | EUR 1390 |
SS-A (Ro) Antigen |
|||
| MBS318013-5x1000Units | MyBiosource | 5x1000Units | EUR 6020 |
SS-A (Ro) Antigen |
|||
| MBS318128-02mg | MyBiosource | 0.2mg | EUR 1420 |
SS-A (Ro) Antigen |
|||
| MBS318128-5x02mg | MyBiosource | 5x0.2mg | EUR 6135 |
Ro/SS-A Antigen |
|||
| MBS611481-2mL | MyBiosource | 2mL | EUR 445 |
Ro/SS-A Antigen |
|||
| MBS611481-5x2mL | MyBiosource | 5x2mL | EUR 1850 |
SS-A / Ro Antigen Antibody |
|||
| abx022699-2ml | Abbexa | 2 ml | EUR 594 |
SS-A / Ro Antigen Antibody |
|||
| abx022699-400l | Abbexa | 400 µl | Ask for price |
SS-A / Ro Antigen Antibody |
|||
| abx022699-80l | Abbexa | 80 µl | EUR 575 |
OPMA04224-200UG - SS-A (Ro) Antigen Protein |
|||
| OPMA04224-200UG | Aviva Systems Biology | 0.2MG | EUR 1499 |
SS-A Antigen |
|||
| E61A00301 | EnoGene | 1mg | EUR 750 |
SS-A Antigen |
|||
| MBS569398-1mg | MyBiosource | 1mg | EUR 1705 |
SS-A Antigen |
|||
| MBS569398-5x1mg | MyBiosource | 5x1mg | EUR 7395 |
SS-A Antigen |
|||
| MBS8506877-1mg | MyBiosource | 1mg | EUR 830 |
SS-A Antigen |
|||
| MBS8506877-5x1mg | MyBiosource | 5x1mg | EUR 3595 |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651596-1000Units | MyBiosource | 1000Units | EUR 1730 |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651596-5x1000Units | MyBiosource | 5x1000Units | EUR 7555 |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651597-02mg | MyBiosource | 0.2mg | EUR 1395 |
Ro/SS-A Antigen (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS651597-5x02mg | MyBiosource | 5x0.2mg | EUR 6060 |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-001mg | MyBiosource | 0.01mg | EUR 375 |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-005mg | MyBiosource | 0.05mg | EUR 525 |
Ro-60/SS-A Antigen (60kD), Recombinant, Human (SSA1, Sjogren Syndrome Antigen A1, 52kD Ribonucleoprotein Autoantigen SS-A/Ro, RO52, RNF81, Tripartite Motif Protein 21, TRIM21) |
|||
| MBS635764-5x005mg | MyBiosource | 5x0.05mg | EUR 2210 |
Borrelia Afzelii Antigen |
|||
| NAT41583-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Afzelii Antigen |
|||
| NAT41583-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Borrelia Garinii Antigen |
|||
| NAT41584-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Harvested bacteria are washed and detergent solubilized to produce a cytoplasmic extract enriched with lipoproteins and outer surface proteins (OSPs). The antigen is presented in phosphate buffered saline containing 1 % n-octyl-β-D-glucopyranoside. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Brucella Abortus Antigen |
|||
| NAT41599-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Brucella abortus lysate, produced by fermentation. |
|||
Candida Albicans Antigen |
|||
| NAT41601-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Candida Albicans Antigen |
|||
| NAT41601-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Candida albicans is grown on solid medium, washed, disrupted and subjected to an extraction process. The antigen consists of cytoplasmic and cell wall components. |
|||
Canine Parvovirus Antigen |
|||
| NAT41594-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Parvovirus, produced in CRFK cells. |
|||
Canine Coronavirus Antigen |
|||
| NAT41590-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Coronavirus produced in A-72 cells. |
|||
Feline Calicivirus Antigen |
|||
| NAT41595-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Calicivirus produced in FC 3TG cells. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Helicobacter Pylori Antigen |
|||
| NAT41603-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Bacteria are cultured on solid medium, harvested, washed and solubilised. The antigen is partially purified by detergent extraction and centrifugation. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Campylobacter Jejuni Antigen |
|||
| NAT41600-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Campylobacter jejuni is cultured on solid medium. This antigen is a partially purified detergent extract of the membrane fraction. The main component is an outer membrane protein, approximately 45 kDa in SDS-PAGE. |
|||
Chlamydia Trachomatis Antigen |
|||
| CT022-1000 | The Native Antigen Company | 1.0 | EUR 382.41 |
|
Description: Chlamydia trachomatis antigens from clarified cell lysate. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-1000 | The Native Antigen Company | 1.0 | EUR 1019.75 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Mycoplasma Pneumoniae Antigen |
|||
| MP901-200 | The Native Antigen Company | 0.2 | EUR 272.96 |
|
Description: Mycoplasma pneumoniae whole organisms that have been purified and detergent treated to enrich antigenic proteins and decrease background. |
|||
Neisseria Gonorrhoeae Antigen |
|||
| NG01-1000 | The Native Antigen Company | 1.0 | EUR 382.41 |
|
Description: Homogenised lysate of pure bacteria. |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Echovirus Antigen, Recombinant |
|||
| REC31776-500 | The Native Antigen Company | 0.5 | EUR 1053.23 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus |
|||
Trichomonas Vaginalis Antigen |
|||
| TV01-1000 | The Native Antigen Company | 1.0 | EUR 424.9 |
|
Description: Washed & lysed suspension of whole protozoa |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Echinococcus Granulosus Antigen |
|||
| NAT41602-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Echinococcus granulosus material is derived from bovine hydatid cyst as sterile filtered cyst fluid. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-100 | The Native Antigen Company | 0.1 | EUR 279.4 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Enterovirus Antigen, Recombinant |
|||
| REC31772-500 | The Native Antigen Company | 0.5 | EUR 1053.23 |
|
Description: Proprietary recombinant antigen expressed in E. coli and purified by chromatography. Individually pooled antigens shown to react with QC serum panel (multiple negative, borderline and positive sera) within defined reactivity range in Coxsackie-/Echovirus IgA, IgG and IgM ELISA. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-100 | The Native Antigen Company | 0.1 | EUR 321.89 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-1000 | The Native Antigen Company | 1.0 | EUR 2115.47 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Cytomegalovirus Purified Antigen |
|||
| CMV-HP-500 | The Native Antigen Company | 0.5 | EUR 1291.43 |
|
Description: A concentrated source of human Cytomegalovirus particles purified by sucrose gradient ultracentrifugation. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-1000 | The Native Antigen Company | 1.0 | EUR 1669.97 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Astrovirus Antigen (Type 1) |
|||
| AS02-200 | The Native Antigen Company | 0.2 | EUR 446.78 |
|
Description: A concentrated source of Astrovirus particles and Astrovirus proteins from a lysate of host cells. |
|||
Yersinia pestis V antigen |
|||
| REC32028-100 | The Native Antigen Company | 0.1 | EUR 326.34 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Yersinia pestis V antigen |
|||
| REC32028-500 | The Native Antigen Company | 0.5 | EUR 1386.95 |
|
Description: Yersinia pestis V antigen (LcrV antigen, capsule protein fraction 1, type III secretion system needle tip protein). The protein is produced as an N-terminal GST fusion, with GST being cleaved by thrombin and is not present in the final product. |
|||
Canine Herpes Virus Antigen |
|||
| NAT41592-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Herpes virus, produced in MDCK cells. |
|||
Canine Adenovirus 1 Antigen |
|||
| NAT41587-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Adenovirus Type 1, produced in A-72 cells. |
|||
Canine Adenovirus 2 Antigen |
|||
| NAT41588-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Adenovirus Type 2, produced in A-72 cells. |
|||
Toxoplasma gondii IgM antigen |
|||
| TG-IgM-100 | The Native Antigen Company | 0.1mg | EUR 139.86 |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
Toxoplasma gondii IgM antigen |
|||
| TG-IgM-1000 | The Native Antigen Company | 1.0mg | EUR 1189.51 |
|
Description: A highly purified source of Toxoplasma gondii membrane antigens, optimised for IgM detection. |
|||
Canine Distemper Virus Antigen |
|||
| NAT41591-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Distemper virus, produced in SL-29 cells. |
|||
Canine Parainfluenza Virus Antigen |
|||
| NAT41593-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Canine Parainfluenza virus antigen, produced in MDCK cells. |
|||
Feline Panleukopenia Virus Antigen |
|||
| NAT41597-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Panleukopenia Virus (FPLV; feline parvovirus) antigen, produced in CRFK cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-100 | The Native Antigen Company | 0.1 | EUR 305.15 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-1000 | The Native Antigen Company | 1.0 | EUR 1847.65 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Norovirus GII.4 VP1 Antigen |
|||
| REC31620-500 | The Native Antigen Company | 0.5 | EUR 1076.4 |
|
Description: Recombinant Norovirus GII.4 VP1 antigen produced in 293 human cells. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-100 | The Native Antigen Company | 0.1 | EUR 225.32 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Cytomegalovirus Cell Lysate Antigen |
|||
| CMV-CL-1000 | The Native Antigen Company | 1.0 | EUR 1435.63 |
|
Description: A clarified cell lysate containing a mix of CMV antigens from all stages of the replication life cycle. |
|||
Feline Viral Rhinotracheitis Antigen |
|||
| NAT41598-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Viral Rhinotracheitis (FVR; feline herpes virus, FHV-1) antigen, produced in CRFK cells. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-1000 | The Native Antigen Company | 1.0 | EUR 1189.71 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 1 Antigen |
|||
| HS105-200 | The Native Antigen Company | 0.2 | EUR 297.43 |
|
Description: HSV-1 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-1000 | The Native Antigen Company | 1.0 | EUR 1189.71 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Herpes Simplex Virus 2 Antigen |
|||
| HS205-200 | The Native Antigen Company | 0.2 | EUR 297.43 |
|
Description: HSV-2 particles from a cell lysate are purified by sucrose gradient ultracentrifugation. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-100 | The Native Antigen Company | 0.1 | EUR 764.81 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Ross River Virus Recombinant Antigen |
|||
| REC31969-500 | The Native Antigen Company | 0.5 | EUR 2871.26 |
|
Description: Recombinant Ross River virus antigen expressed in HEK293 cells as virus-like particles and purified by sucrose density gradients and precipitation. Virus-like particles were then solubilized in PBS containing 0.2% SDS to prevent aggregation of particles. The preparation is not particulate. Antigens in the preparation include Envelope proteins 1 and 2 and Nucleoprotein. |
|||
Canine Adenovirus 1 and 2 Antigen |
|||
| NAT41589-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: A mixture of Canine Adenovirus Type 1 and Type 2, produced in A-72 cells. |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-100 | The Native Antigen Company | 0.1 | EUR 460.95 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus E Antigen (HBeAg) |
|||
| REC31677-500 | The Native Antigen Company | 0.5 | EUR 1382.84 |
|
Description: Recombinant Hepititis B Virus E Protein (HBeAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-100 | The Native Antigen Company | 0.1 | EUR 460.95 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis B Virus Core Antigen (HBcAg) |
|||
| REC31689-500 | The Native Antigen Company | 0.5 | EUR 1382.84 |
|
Description: Recombinant Hepititis B Virus Core Protein (HBcAg). |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-100 | The Native Antigen Company | 0.1 | EUR 489.27 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Hepatitis C Virus Core Antigen (HCcAg) |
|||
| REC31693-500 | The Native Antigen Company | 0.5 | EUR 1469.11 |
|
Description: Recombinant Hepatitis C Virus core protein is produced in E. coli and fused with a His-tag. |
|||
Feline Infectious Peritonitis Virus Antigen |
|||
| NAT41596-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Feline Infectious Peritonitis virus (FIPV; feline coronavirus) antigen, produced in CRFK cells. |
|||
OPEF01636-1MG - Recombinant SS-A Antigen |
|||
| OPEF01636-1MG | Aviva Systems Biology | 1mg | EUR 1683 |
Herpes Simplex Virus 1 Lysate Antigen |
|||
| HS104-1000 | The Native Antigen Company | 1.0 | EUR 272.96 |
|
Description: A high concentration of HSV-1 particles and proteins from a clarified cell lysate. |
|||
Herpes Simplex Virus 2 Lysate Antigen |
|||
| HS204-1000 | The Native Antigen Company | 1.0 | EUR 272.96 |
|
Description: A high concentration of HSV-2 particles and proteins from a clarified cell lysate. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-1000 | The Native Antigen Company | 1.0 mg | EUR 338 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-200 | The Native Antigen Company | 0.2 mg | EUR 174.83 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Toxoplasma gondii IgG antigen, RH strain |
|||
| TG-IgG-5000 | The Native Antigen Company | 5.0 mg | EUR 1436.48 |
|
Description: A concentrated source of Toxoplasma gondii tachyzoite antigens, optimised for IgG detection, diluted to 0.5 mg/ml. |
|||
Legionella pneumophila antigen (native extract) |
|||
| NAT41580-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Legionella pneumophila antigen from culture. |
|||
Streptococcus Pneumoniae Antigen, Native Extract |
|||
| NAT41604-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Streptococcus pneumoniae antigen from culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-100 | The Native Antigen Company | 0.1 | EUR 395.28 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
Leptospira Biflexa Antigen (Strain Patoc 1) |
|||
| NAT41582-500 | The Native Antigen Company | 0.5 | EUR 1187.13 |
|
Description: Inactivated Leptospira biflexa antigen (Strain Patoc 1) from broth culture. |
|||
SS-B Antigen |
|||
| E61A00401 | EnoGene | 1mg | EUR 750 |
SS-B Antigen |
|||
| MBS569399-1mg | MyBiosource | 1mg | EUR 1705 |
SS-B Antigen |
|||
| MBS569399-5x1mg | MyBiosource | 5x1mg | EUR 7395 |
SS-B Antigen |
|||
| MBS8506643-1mg | MyBiosource | 1mg | EUR 830 |
SS-B Antigen |
|||
| MBS8506643-5x1mg | MyBiosource | 5x1mg | EUR 3595 |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS618195-02mg | MyBiosource | 0.2mg | EUR 905 |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS618195-5x02mg | MyBiosource | 5x0.2mg | EUR 3930 |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-005mg | MyBiosource | 0.05mg | EUR 620 |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-02mg | MyBiosource | 0.2mg | EUR 1050 |
Calreticulin (CALR, SSA, Sicca Syndrome Antigen A, Ro, Autoantigen Ro) |
|||
| MBS616022-5x02mg | MyBiosource | 5x0.2mg | EUR 4580 |